ArticleFrontiers in oncology2026
An interpretable MRI radiomics approach for preoperative prediction of lymphovascular space invasion in cervical cancer using optimal peritumoral region.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lymphovascular space invasion (LVSI) is an important pathological feature associated with tumor aggressiveness and adverse prognosis in cervical cancer. However, reliable preoperative prediction of LVSI remains a challenge. This study aimed to develop and validate an MRI-based radiomics model incorporating intratumoral and peritumoral features for LVSI prediction and systematically evaluate the optimal peritumoral extent. Materials and methods: In this single-center study comprising both retrospective and prospective cohorts, 204 patients with pathologically confirmed cervical cancer were randomly divided into a training cohort (n = 142) and a test cohort (n = 62). Radiomics features were extracted from the intratumoral and peritumoral regions with expansion distances of 1, 3, and 5 mm. Feature selection was performed using intraclass correlation coefficient (ICC) analysis, minimum redundancy maximum relevance (mRMR), and least absolute shrinkage and selection operator (LASSO) analysis. Six machine learning algorithms, including logistic regression [LR], support vector machine, random forest, ExtraTrees, LightGBM, and multilayer perceptron, were used to construct the predictive models. The model performance was evaluated using receiver operating characteristic analysis, calibration curves, and decision curve analysis. SHapley Additive Explanations (SHAP) were applied to interpret the optimal models. Results: Among all ROI configurations, the Intra+P1 model demonstrated the best overall performance, particularly when it was combined with LR. The LR-based Intra+P1 model achieved an AUC of 0.866 (95% CI: 0.807-0.926) in the training cohort and 0.843 (95% CI: 0.731-0.955) in the test cohort respectively. Increasing the peritumoral expansion from 1 mm to 3 mm or 5 mm did not further improve predictive performance. The addition of clinical variables (tumor diameter and SCC level) did not provide a significant incremental predictive value. Calibration and decision curve analyses demonstrated good agreement and favorable clinical utility of the model. SHAP analysis showed that both intratumoral and peritumoral features contributed substantially to the model prediction, with texture features playing a dominant role. Conclusion: This interpretable MRI-based radiomics model facilitates accurate preoperative prediction of LVSI in cervical cancer. A narrowly defined 1-mm peritumoral region provides the most informative complementary information, underscoring the importance of the tumor-invading front. This approach offers a noninvasive tool for risk stratification and may support individualized treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.